Table 1.
Demographic information of all patients and different outcomes.
| All Patients (n = 36) |
Effective Outcome (n = 22) |
Poor Outcome (n = 14) |
ap Value | |
|---|---|---|---|---|
| Gender, n (%) | 0.217 | |||
| Female | 28 (77.8) | 19 (86.4) | 9 (64.3) | |
| Male | 8 (22.2) | 3 (13.6) | 5 (35.7) | |
| Age (year) ± SE (range) | 59.2 ± 1.6 (34–77) | 57.8 ± 1.9 (34–67) | 61.4 ± 2.7 (39–77) | 0.267 |
| BH (cm) ± SE (range) | 157.6 ± 1.0 (148–174) | 158.3 ± 1.5 (148–174) | 156.5 ± 1.3 (150–165) | 0.810 |
| BW (kg) ± SE (range) | 62.6 ± 1.9 (45–93) | 63.4 ± 2.8 (46–93) | 61.4 ± 2.4 (45–75) | 0.936 |
| DM (%) | 10 (27.8) | 6 (27.3) | 4 (28.6) | 0.932 |
| Hypertension (%) | 8 (22.2) | 6 (27.3) | 2 (14.3) | 0.441 |
| Lesion site, n (%) | 0.879 | |||
| Left | 16 (44.4) | 10 (45.5) | 6 (42.9) | |
| Right | 20 (55.6) | 12 (54.5) | 8 (57.1) | |
| Duration (month) ± SE (range) | 15.1 ± 2.4 (1–48) | 15.1 ± 3.1 (2–40) | 15.1 ± 4.1 (1–48) | 0.689 |
| Classification (%) | 0.175 | |||
| Persistent | 23 (63.9) | 12 (54.5) | 11 (78.6) | |
| Recurrent | 13 (36.1) | 10 (45.5) | 3 (21.4) | |
| CSA (mm2) (SE) | 14.1 ± 0.8 | 14.3 ± 1.2 | 13.6 ± 0.9 | 0.835 |
| No. of injection (SE) | 3.1 ± 0.3 | 3.1 ± 0.5 | 3.2 ± 0.5 | 0.597 |
| Other treatment, (%) | 11 (30.6) | 5 (22.7) | 6 (42.9) | 0.671 |
| Follow-up period (month), (SE) (range) | 33.0 ± 2.8 (6–67) | 35.9 ± 3.6 (7–67) | 28.5 ± 4.4 (6–55) | 0.160 |
BH = Body height; BW = Body weight; DM = Diabetes mellitus; CSA = Cross-sectional area; SE = standard error. a Mann–Whitney U Test, Fisher’s exact test.